Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abildgaard C. F. Recognition and treatment of intravascular coagulation. J Pediatr. 1969 Feb;74(2):163–176. doi: 10.1016/s0022-3476(69)80064-8. [DOI] [PubMed] [Google Scholar]
- Brain M. C., Baker L. R., McBride J. A., Rubenberg M. L., Dacie J. V. Treatment of patients with microangiopathic haemolytic anaemia with heparin. Br J Haematol. 1968 Dec;15(6):603–621. doi: 10.1111/j.1365-2141.1968.tb01582.x. [DOI] [PubMed] [Google Scholar]
- Das P. C., Allan A. G., Woodfield D. G., Cash J. D. Fibrin degradation products in sera of normal subjects. Br Med J. 1967 Dec 23;4(5581):718–720. doi: 10.1136/bmj.4.5581.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gilchrist G. S., Lieberman E., Ekert H., Fine R. N., Grushkin C. Heparin therapy in the haemolytic-uraemic syndrome. Lancet. 1969 Jun 7;1(7606):1123–1126. doi: 10.1016/s0140-6736(69)91644-4. [DOI] [PubMed] [Google Scholar]
- Israels E. D., Rayner H., Israels L. G., Zipursky A. A microhemagglutination-inhibition assay for the quantitation of fibrinogen breakdown products. J Lab Clin Med. 1968 Feb;71(2):333–337. [PubMed] [Google Scholar]
- Monnens L., Schretlen E. Intravascular coagulation in an infant with the hemolytic-uremic syndrome. Acta Paediatr Scand. 1967 Jul;56(4):436–441. doi: 10.1111/j.1651-2227.1967.tb15403.x. [DOI] [PubMed] [Google Scholar]
- Uttley W. S., Allan A. G., Cash J. D. Fibrin-fibrinogen degradation products in sera of normal infants and children. Arch Dis Child. 1969 Dec;44(238):761–764. doi: 10.1136/adc.44.238.761. [DOI] [PMC free article] [PubMed] [Google Scholar]